Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination.
Pohla H, Buchner A, Stadlbauer B, Frankenberger B, Stevanovic S, Walter S, Frank R, Schwachula T, Olek S, Kopp J, Willimsky G, Stief CG, Hofstetter A, Pezzutto A, Blankenstein T, Oberneder R, Schendel DJ. Pohla H, et al. Among authors: schendel dj. Mol Med. 2013 Feb 8;18(1):1499-508. doi: 10.2119/molmed.2012.00221. Mol Med. 2013. PMID: 23269976 Free PMC article. Clinical Trial.
Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells.
Frankenberger B, Regn S, Geiger C, Noessner E, Falk CS, Pohla H, Javorovic M, Silberzahn T, Wilde S, Buchner A, Siebels M, Oberneder R, Willimsky G, Pezzutto A, Blankenstein T, Schendel DJ. Frankenberger B, et al. Among authors: schendel dj. World J Urol. 2005 Jul;23(3):166-74. doi: 10.1007/s00345-005-0505-5. Epub 2005 Jul 5. World J Urol. 2005. PMID: 15997395 Review.
Immune suppression in renal cell carcinoma.
Frankenberger B, Noessner E, Schendel DJ. Frankenberger B, et al. Among authors: schendel dj. Semin Cancer Biol. 2007 Aug;17(4):330-43. doi: 10.1016/j.semcancer.2007.06.004. Epub 2007 Jun 23. Semin Cancer Biol. 2007. PMID: 17656104 Review.
Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma.
Buchner A, Pohla H, Willimsky G, Frankenberger B, Frank R, Baur-Melnyk A, Siebels M, Stief CG, Hofstetter A, Kopp J, Pezzutto A, Blankenstein T, Oberneder R, Schendel DJ. Buchner A, et al. Among authors: schendel dj. Hum Gene Ther. 2010 Mar;21(3):285-97. doi: 10.1089/hum.2008.192. Hum Gene Ther. 2010. PMID: 19788391 Clinical Trial.
Allogeneic vaccination for renal cell carcinoma: development and monitoring.
Pohla H, Frankenberger B, Stadlbauer B, Oberneder R, Hofstetter A, Willimsky G, Pezzutto A, Dörken B, Blankenstein T, Schendel DJ. Pohla H, et al. Among authors: schendel dj. Bone Marrow Transplant. 2000 May;25 Suppl 2:S83-7. doi: 10.1038/sj.bmt.1702362. Bone Marrow Transplant. 2000. PMID: 10933197
Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response.
Rüttinger D, van den Engel NK, Winter H, Schlemmer M, Pohla H, Grützner S, Wagner B, Schendel DJ, Fox BA, Jauch KW, Hatz RA. Rüttinger D, et al. Among authors: schendel dj. J Transl Med. 2007 Sep 14;5:43. doi: 10.1186/1479-5876-5-43. J Transl Med. 2007. PMID: 17868452 Free PMC article. Clinical Trial.
188 results